| Matthew T Larsen, DPM | |
|
8400 Washington Ave, Mount Pleasant, WI 53406-3735 | |
| (262) 884-4000 | |
| Not Available |
| Full Name | Matthew T Larsen |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 28 Years |
| Location | 8400 Washington Ave, Mount Pleasant, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417944737 | NPI | - | NPPES |
| 43226300 | Medicaid | WI | |
| 4388570001 | Other | WI | DMERC REGION B CARRIER |
| 213E00000X | Other | TAXONOMY CODE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 775 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora Medical Center Kenosha | Kenosha, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
Current research suggests that Mycobacterium tuberculosis can evade the immune response. The related report by Rahman et al, "Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory T cells in the granulomatous lesions," appears in the June 2009 issue of The American Journal of Pathology.
US-Australian drug discovery company, Novogen Limited, today announced details of an in vivo proof of concept study that demonstrates their lead anti-tropomyosin drug candidate, Anisina, has the potential to improve the effectiveness of chemotherapy in children and reduce life-long side-effects.
AIDS Healthcare Foundation (AHF), the largest global AIDS organization, responded to today's announcement by the Obama Administration that it will allocate $30 million in funding to address the national AIDS Drug Assistance Program crisis that has left 3,000 Americans on waiting lists to receive lifesaving AIDS medications by saying "Thank you, but it is not nearly enough."
We may be closer to predicting who is at risk for a heart attack, according to a recently published Spectrum Health study. Researchers with Spectrum Health's Frederik Meijer Heart & Vascular Institute used new imaging technology on patients being treated for heart attacks.
› Verified 2 days ago
| Provider Name | Ascension Medical Group-southeast Wisconsin Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1609881077 PECOS PAC ID: 8628980943 Enrollment ID: O20031104000421 |
News Archive
Current research suggests that Mycobacterium tuberculosis can evade the immune response. The related report by Rahman et al, "Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory T cells in the granulomatous lesions," appears in the June 2009 issue of The American Journal of Pathology.
US-Australian drug discovery company, Novogen Limited, today announced details of an in vivo proof of concept study that demonstrates their lead anti-tropomyosin drug candidate, Anisina, has the potential to improve the effectiveness of chemotherapy in children and reduce life-long side-effects.
AIDS Healthcare Foundation (AHF), the largest global AIDS organization, responded to today's announcement by the Obama Administration that it will allocate $30 million in funding to address the national AIDS Drug Assistance Program crisis that has left 3,000 Americans on waiting lists to receive lifesaving AIDS medications by saying "Thank you, but it is not nearly enough."
We may be closer to predicting who is at risk for a heart attack, according to a recently published Spectrum Health study. Researchers with Spectrum Health's Frederik Meijer Heart & Vascular Institute used new imaging technology on patients being treated for heart attacks.
› Verified 2 days ago
| Provider Name | Aurora Medical Group, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
Current research suggests that Mycobacterium tuberculosis can evade the immune response. The related report by Rahman et al, "Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory T cells in the granulomatous lesions," appears in the June 2009 issue of The American Journal of Pathology.
US-Australian drug discovery company, Novogen Limited, today announced details of an in vivo proof of concept study that demonstrates their lead anti-tropomyosin drug candidate, Anisina, has the potential to improve the effectiveness of chemotherapy in children and reduce life-long side-effects.
AIDS Healthcare Foundation (AHF), the largest global AIDS organization, responded to today's announcement by the Obama Administration that it will allocate $30 million in funding to address the national AIDS Drug Assistance Program crisis that has left 3,000 Americans on waiting lists to receive lifesaving AIDS medications by saying "Thank you, but it is not nearly enough."
We may be closer to predicting who is at risk for a heart attack, according to a recently published Spectrum Health study. Researchers with Spectrum Health's Frederik Meijer Heart & Vascular Institute used new imaging technology on patients being treated for heart attacks.
› Verified 2 days ago
| Provider Name | Foot & Ankle Specialists Of Racine, S.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457337024 PECOS PAC ID: 1456426675 Enrollment ID: O20080821000519 |
News Archive
Current research suggests that Mycobacterium tuberculosis can evade the immune response. The related report by Rahman et al, "Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory T cells in the granulomatous lesions," appears in the June 2009 issue of The American Journal of Pathology.
US-Australian drug discovery company, Novogen Limited, today announced details of an in vivo proof of concept study that demonstrates their lead anti-tropomyosin drug candidate, Anisina, has the potential to improve the effectiveness of chemotherapy in children and reduce life-long side-effects.
AIDS Healthcare Foundation (AHF), the largest global AIDS organization, responded to today's announcement by the Obama Administration that it will allocate $30 million in funding to address the national AIDS Drug Assistance Program crisis that has left 3,000 Americans on waiting lists to receive lifesaving AIDS medications by saying "Thank you, but it is not nearly enough."
We may be closer to predicting who is at risk for a heart attack, according to a recently published Spectrum Health study. Researchers with Spectrum Health's Frederik Meijer Heart & Vascular Institute used new imaging technology on patients being treated for heart attacks.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew T Larsen, DPM 3301 W Forest Home Ave, Milwaukee, WI 53215-2843 Ph: () - | Matthew T Larsen, DPM 8400 Washington Ave, Mount Pleasant, WI 53406-3735 Ph: (262) 884-4000 |
News Archive
Current research suggests that Mycobacterium tuberculosis can evade the immune response. The related report by Rahman et al, "Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory T cells in the granulomatous lesions," appears in the June 2009 issue of The American Journal of Pathology.
US-Australian drug discovery company, Novogen Limited, today announced details of an in vivo proof of concept study that demonstrates their lead anti-tropomyosin drug candidate, Anisina, has the potential to improve the effectiveness of chemotherapy in children and reduce life-long side-effects.
AIDS Healthcare Foundation (AHF), the largest global AIDS organization, responded to today's announcement by the Obama Administration that it will allocate $30 million in funding to address the national AIDS Drug Assistance Program crisis that has left 3,000 Americans on waiting lists to receive lifesaving AIDS medications by saying "Thank you, but it is not nearly enough."
We may be closer to predicting who is at risk for a heart attack, according to a recently published Spectrum Health study. Researchers with Spectrum Health's Frederik Meijer Heart & Vascular Institute used new imaging technology on patients being treated for heart attacks.
› Verified 2 days ago
Anne P Stroze, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 8400 Washington Ave, Mount Pleasant, WI 53406 Phone: 262-884-4000 Fax: 262-884-4177 | |
Cynthia Rae Cernak, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3805b Spring St Ste 130, Mount Pleasant, WI 53405 Phone: 262-631-8750 Fax: 262-631-8754 | |
G.s. Miceli, Dpm, S.c. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 6754 Lindermann Ave, Mount Pleasant, WI 53406 Phone: 262-654-5555 Fax: 262-654-9333 |